Drug Design Development and Therapy

Scope & Guideline

Elevating Drug Discovery with High-Impact Research

Introduction

Explore the comprehensive scope of Drug Design Development and Therapy through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Drug Design Development and Therapy in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1177-8881
PublisherDOVE MEDICAL PRESS LTD
Support Open AccessYes
CountryNew Zealand
TypeJournal
Convergefrom 2007 to 2024
AbbreviationDRUG DES DEV THER / Drug Des. Dev. Ther.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND

Aims and Scopes

The journal 'Drug Design Development and Therapy' focuses on advancing the field of drug development and therapeutic strategies through rigorous research that encompasses a variety of methodologies and disciplines.
  1. Drug Discovery and Development:
    The journal emphasizes original research articles that explore novel drug candidates, their mechanisms of action, and the methodologies involved in the drug development process.
  2. Pharmacology and Toxicology:
    Articles in this area assess the pharmacokinetics, pharmacodynamics, and toxicological profiles of various compounds, providing critical insights into their therapeutic potential.
  3. Clinical Applications and Trials:
    The journal publishes clinical studies, trials, and retrospective analyses that evaluate the efficacy and safety of drugs and treatment protocols in real-world settings.
  4. Integrative Approaches in Medicine:
    Research that combines traditional medicine with modern pharmacological techniques, particularly those utilizing network pharmacology and systems biology, is a significant focus.
  5. Innovative Drug Delivery Systems:
    The journal covers advancements in drug delivery technologies, including nanotechnology and biopolymer-based systems, aimed at enhancing therapeutic efficacy and patient compliance.
  6. Natural Products and Traditional Medicine:
    There is a consistent focus on the pharmacological properties of natural compounds and traditional medicine formulations, illustrating their roles in modern therapeutic applications.
The journal has observed notable trends and emerging themes that highlight its dynamic nature and responsiveness to contemporary issues in drug design and therapy.
  1. Network Pharmacology and Systems Biology:
    There is a growing trend towards the use of network pharmacology and systems biology approaches to understand drug interactions, mechanisms of action, and to identify therapeutic targets.
  2. Personalized Medicine:
    Research focusing on personalized or precision medicine is on the rise, reflecting a shift towards tailoring therapies based on individual patient profiles and genetic backgrounds.
  3. Integrative and Complementary Approaches:
    There is an increasing interest in the integration of traditional medicine with modern pharmacological methods, exploring the efficacy of herbal and natural products in contemporary therapeutic applications.
  4. Nanotechnology in Drug Delivery:
    The application of nanotechnology in drug delivery systems is emerging as a critical area of focus, aimed at improving bioavailability and targeting specific tissues or cells.
  5. Longitudinal and Real-World Evidence Studies:
    The journal is increasingly publishing longitudinal studies and real-world evidence research that assess the long-term efficacy and safety of treatments in diverse patient populations.
  6. Immunotherapy and Biologics:
    There is a noticeable trend towards research in immunotherapeutic agents and biologics, reflecting the growing importance of these therapies in the treatment of various diseases, particularly cancers.

Declining or Waning

While the journal continues to thrive in several research areas, some themes have shown a decline in prominence, reflecting changing priorities and advancements in the field.
  1. Conventional Pharmaceutical Approaches:
    Research focused solely on conventional pharmaceutical drugs without consideration of integrative or novel approaches appears to be waning, as the field shifts towards more innovative and holistic strategies.
  2. Single-Agent Studies:
    There is a noticeable reduction in studies that evaluate the efficacy of single-agent therapies, as combination therapies and multi-target strategies become more favorable in clinical settings.
  3. Basic Science Studies:
    Research with a purely basic science focus, lacking translational or clinical relevance, is increasingly less common, as the journal emphasizes studies with direct implications for drug development and therapy.
  4. Short-Term Efficacy Studies:
    The focus on short-term efficacy and safety studies is diminishing, with a greater emphasis now being placed on long-term outcomes and the comprehensive assessment of therapeutic regimens.

Similar Journals

BIOORGANIC & MEDICINAL CHEMISTRY

Innovating Drug Discovery Through Chemistry
Publisher: PERGAMON-ELSEVIER SCIENCE LTDISSN: 0968-0896Frequency: 24 issues/year

BIOORGANIC & MEDICINAL CHEMISTRY, published by Pergamon-Elsevier Science Ltd, is a prominent journal in the fields of biochemical research and drug discovery, with an ISSN of 0968-0896 and an E-ISSN of 1464-3391. Established in 1993, it has garnered respect and recognition, evidenced by its categorization in various quartile ranks across 2023, including Q2 in Clinical Biochemistry and Pharmaceutical Science. It holds significant Scopus rankings, placing it in the 75th percentile in Pharmaceutical Science and 74th percentile in Organic Chemistry, highlighting its influential contributions to ongoing research and developments. This journal provides a platform for disseminating advancements in bioorganic and medicinal chemistry, focusing on innovative methodologies, therapeutic advancements, and molecular pharmacology. Although it does not follow an open-access model, it remains a key resource for researchers, professionals, and students aiming to stay at the forefront of scientific discovery in the UK and beyond. The journal’s commitment to enhancing knowledge within the biomedical community makes it an essential read for those passionate about this dynamic field.

International Journal of Pharmacology

Fostering Global Dialogue in Pharmacology and Toxicology
Publisher: ASIAN NETWORK SCIENTIFIC INFORMATION-ANSINETISSN: 1811-7775Frequency: 8 issues/year

Welcome to the International Journal of Pharmacology, a key publication in the field of pharmacology, published by ASIAN NETWORK SCIENTIFIC INFORMATION (ANSINET). Since its inception in 2006, this journal has provided a vital platform for researchers and professionals to disseminate their findings and insights in pharmacology, toxicology, and pharmaceutics. Despite recent discontinuation in Scopus coverage, the journal's dedication to fostering scientific dialogue continues to attract contributions from esteemed scholars globally. With an **ISSN of 1811-7775** and **E-ISSN of 1812-5700**, the journal seeks to bridge the gap between laboratory research and clinical application, promoting a deeper understanding of drug actions and interactions. Although it operates under traditional access options, the relevance of its published studies to ongoing pharmacological research remains significant.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Elevating clinical practice with evidence-based insights.
Publisher: DUSTRI-VERLAG DR KARL FEISTLEISSN: 0946-1965Frequency: 12 issues/year

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, published by DUSTRI-VERLAG DR KARL FEISTLE in Germany, is a vital scholarly platform dedicated to advancing the field of pharmacology through rigorous research and innovative therapeutic strategies. Established in 1994, this journal has maintained its relevance in the evolving landscape of clinical pharmacology, achieving a Q3 rank in both general and medical pharmacology categories as of 2023. With an ISSN of 0946-1965, it is positioned as an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding of drug therapy and pharmacological applications. Though it currently does not offer open access, its comprehensive scope covers a wide array of topics within pharmacology, promising to contribute significantly to scientific discussions and knowledge dissemination from 1994 to 2024. Whether you are looking for the latest studies or historical insights, the journal remains a fixture for anyone invested in the pharmacological sciences.

SCIENTIA PHARMACEUTICA

Fostering collaboration and discovery in pharmaceutical sciences.
Publisher: MDPIISSN: Frequency: 4 issues/year

SCIENTIA PHARMACEUTICA, published by MDPI in Switzerland, is a leading open access journal dedicated to advancing the field of pharmaceutical sciences since 2006. With a focus on pharmacology, toxicology, and pharmaceutics, this journal plays a pivotal role in disseminating high-quality research and innovative findings. It boasts an impressive impact factor and is ranked in the second quartile (Q2) for Pharmaceutical Science, signifying its influence within the academic community, aided by a Scopus ranking of 74 out of 183 journals in the same category. SCIENTIA PHARMACEUTICA invites original research articles, reviews, and notes that contribute to the understanding and development of pharmaceutical science, making it an essential resource for researchers, professionals, and students alike seeking to stay at the forefront of this continuously evolving field. For those interested in broadening their knowledge and sharing insights, the journal ensures wide accessibility, supporting the open access model for maximum outreach.

Drug Target Insights

Connecting Researchers to Transformative Drug Insights.
Publisher: ABOUTSCIENCE SRLISSN: 1177-3928Frequency: 1 issue/year

Drug Target Insights is a prestigious peer-reviewed journal published by ABOUTSCIENCE SRL, catering to the dynamic field of pharmacology and medicinal biochemistry. With an Open Access policy since 2006, the journal aims to promote the dissemination of cutting-edge research and innovations that target drug discovery and therapeutic developments. Based in Milan, Italy, it boasts a notable impact within its research community, achieving a Q3 classification in the categories of Clinical Biochemistry and Medical Pharmacology in 2023, alongside a robust performance in the Q2 category for Pharmacology, Toxicology, and Pharmaceutics. The journal serves as a vital platform for researchers, professionals, and students seeking to advance their understanding of drug delivery systems, therapeutic targets, and pharmacodynamics. With a commitment to enhancing global access to crucial research findings, Drug Target Insights stands out as an essential resource for those engaged in the ever-evolving landscape of pharmaceutical sciences.

DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY

Advancing Pharmaceutical Innovation and Excellence
Publisher: TAYLOR & FRANCIS LTDISSN: 0363-9045Frequency: 12 issues/year

Drug Development and Industrial Pharmacy is a prestigious journal published by Taylor & Francis Ltd, focusing on the critical field of pharmaceutical sciences. With an ISSN of 0363-9045 and an E-ISSN of 1520-5762, the journal has been an essential resource for researchers and professionals since its inception in 1974. It occupies a crucial niche within Drug Discovery, Organic Chemistry, and Pharmaceutical Science, currently ranked in the second and third quartiles, reflecting its solid contribution to the field. The journal encompasses a wide array of topics, including drug development processes, formulation, and industrial manufacturing alongside cutting-edge research in pharmacology and toxicology. With a commendable Scopus ranking demonstrating high relevance—ranked #44 in Pharmaceutical Science—it serves as a vital forum for academia and industry to share innovative findings and methodologies. While it does not offer open access, the journal remains an invaluable resource for those seeking to advance their knowledge and enhance their research in pharmaceutical development.

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Advancing Knowledge in Pharmacology and Toxicology
Publisher: SPRINGERISSN: 0028-1298Frequency: 12 issues/year

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY is a prestigious journal published by SPRINGER, focusing on the dynamic fields of pharmacology and toxicology. With an ISSN of 0028-1298 and an E-ISSN of 1432-1912, this esteemed publication has been a staple in the scientific community since its inception in 1969, continuing to wield influence with a convergence of research that reaches through 2024. Ranked in the Q2 category for both medicine and pharmacology, it stands at an impressive 111th out of 313 in the Scopus rankings for pharmacology, reflecting its significant impact in the field. Though not offering open access, the journal remains a vital resource for researchers, professionals, and students seeking to explore groundbreaking studies and advancements in pharmacological science. With its high standards and comprehensive coverage, NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY is essential reading for those dedicated to understanding the mechanisms of drug action and the complexities of therapeutic interventions.

European Journal of Pharmacology

Elevating pharmacological knowledge for global healthcare progress.
Publisher: ELSEVIERISSN: 0014-2999Frequency: 24 issues/year

The European Journal of Pharmacology, a prestigious publication by Elsevier, serves as a vital resource in the field of pharmacology, offering rich insights into drug development and therapeutic applications. Since its inception in 1967, this journal has evolved to encompass groundbreaking research, including pharmacokinetics, toxicology, and innovative pharmacological methodologies, making it an essential platform for researchers and professionals alike. With an impressive impact factor that places it in the Q1 category of pharmacological journals and a Scopus ranking of #49 out of 313, the journal is recognized in the 84th percentile within its category, solidifying its significance in the academic community. Although the journal is not open access, it continues to attract contributions from leading scientists worldwide, ensuring that cutting-edge findings are disseminated effectively. The European Journal of Pharmacology not only highlights advancements in drug discovery and clinical applications but also promotes interdisciplinary collaboration, ultimately contributing to the progress of healthcare globally.

Frontiers in Pharmacology

Empowering researchers with cutting-edge insights in pharmacology.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Pharmacology, published by FRONTIERS MEDIA SA, stands as a leading open-access journal dedicated to advancing the field of pharmacology since its inception in 2010. With its ISSN 1663-9812, the journal is based in Switzerland and maintains a vital role in disseminating innovative research findings that span various disciplines within pharmacology, including pharmacokinetics, toxicology, and pharmacogenetics. In 2023, Frontiers in Pharmacology has achieved an impressive standing within the scientific community, being ranked in the Q1 category for both general and medical pharmacology, highlighting its critical contribution to the field with a Scopus ranking of #41 out of 272 in medical pharmacology and #76 out of 313 in pharmacology, toxicology, and pharmaceutics, placing it in the 75th and 85th percentiles, respectively. Researchers and practitioners benefit from its open-access model, which ensures widespread accessibility to groundbreaking research, fostering collaboration and innovation across the pharmaceutical sciences. With its commitment to excellence, Frontiers in Pharmacology serves as an essential resource for those looking to explore and contribute to the latest advancements in pharmacological research.

TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH

Championing open access to vital pharmaceutical knowledge.
Publisher: PHARMACOTHERAPY GROUPISSN: 1596-5996Frequency: 2 issues/year

Tropical Journal of Pharmaceutical Research is an esteemed open-access platform dedicated to advancing the field of pharmaceutical sciences, published by the Pharmacotherapy Group in Nigeria. With an ISSN of 1596-5996 and open access established since 2002, this journal serves as a critical resource for researchers, professionals, and students seeking to disseminate and access high-quality research in both pharmaceutical science and pharmacology. Despite its ranking in the third quartile (Q3) for Pharmaceutical Science and the fourth quartile (Q4) in Pharmacology as of 2023, the journal continues to stand out with its commitment to fostering significant dialogue and innovation in the scientific community. Anchored at the University of Benin, Faculty of Pharmacy, the journal invites contributions that explore novel pharmaceutical research, clinical applications, and drug development, playing a vital role in addressing health challenges that are particularly relevant to tropical regions. Researchers can look forward to publishing their findings in a journal that not only promotes the sharing of knowledge but also enhances the scientific discourse within a rapidly evolving field.